Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

Endocyte allowed to commence Phase III trial in U.S.

The FDA has approved the importation of Endocyte's supply of Doxil from Europe into the U.S. for use in the PROCEED Phase III trial.

Dutch nuke reactor passes emergency disaster tests

The nuclear installations in Petten, The Netherlands, can withstand extreme conditions including flooding events and earthquakes, or a combination of both. This is shown by the results of an in-depth stress test that were sent by Minister Verhagen (The Netherlands Ministry of Economic Affairs, Agriculture and Innovation) to the Dutch Lower Chamber.

Study: Robotic surgery may be superior for HPV-related oral cancer

Robotic surgery conducted through patients mouths provides excellent results in removing squamous cell carcinoma at the back of the throat, with outcomes similar or superior to other surgical and nonsurgical treatments, especially in nonsmoking patients with human papillomavirus (HPV), according to a study published in the March issue of Mayo Clinic Proceedings.

FDA green-lights breast thermography system

The FDA has cleared UE LifeSciences NoTouch BreastScan as an adjunctive diagnostic screening tool for the detection of breast cancer.

Siemens application adds 360 degree rotation to Artis zeego

Siemens Healthcare has released the syngo DynaCT 360 application for the Artis zeego robotic interventional imaging system.

FDA clears portable device for ultrasound-guided procedures

Houston Medical Robotics has received FDA 510(k) clearance to market the Euclid Tier 1 Mini Access System, which is a portable, handheld device that integrates ultrasound imaging systems to facilitate placement of a needle and guidewire into a targeted anatomical location for a variety of therapeutics applications.

AIM: Docs cant make the grade when quizzed about cancer screening

Cancer screening statistics that show benefit in improved survival rates and increased early detection are susceptible to lead-time and overdiagnosis biases, but most primary care physicians dont understand this crucial point. Few can correctly recognize that reduced mortality in a randomized trial is the best evidence of the benefit of screening, according to a study published in the March 6 issue of Annals of Internal Medicine.

FDA rejects Merck's combo cholesterol drug

The FDA has issued a complete response letter regarding Merck's new drug application for ezetimibe (Zetia) and atorvastatin (Lipitor) tablets, an investigational combination medicine.

Displaying 6993 - 7000 of 23568

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.